Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality
This secondary analysis of a randomized clinical trial assesses whether screening for prostate-specific antigen reduces prostate cancer mortality at
Stay updated with breaking news from Relation Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
This secondary analysis of a randomized clinical trial assesses whether screening for prostate-specific antigen reduces prostate cancer mortality at
Leading property firms also call for more tax breaks and improved transport links to hubs ahead of autumn statement
31 May 2023 British Land has established an Innovation Advisory Council to support its continued growth in the life science and innovation sectors. The Council is formed of... | May 31, 2023
Edith Hessel, experienced R&D and biopharma executive, named as Chief Scientific Officer Osteoporosis announced as first indication, driven by Relation's proprietary engine for indication
Oncology and AI-guided drug discovery firms roped in the biggest biotech investments in Europe in June 2022. The leading private rounds went to companies including ImCheck Therapeutics, MiroBio and Charm Therapeutics.